UNDER ETHICAL REVIEW · PRE-DEPLOYMENT PHASE

European Independent AI for Behavioural Recovery Support

A research-grade conversational AI system built outside Big Tech ecosystems — designed to bridge the gender gap in addiction care across Europe.

The problem · Statistical landscape

A gender gap hidden in plain sight

Women represent the majority of Europe's unaddressed addiction burden, yet remain systematically underserved across all 27 EU member states and the United Kingdom.

Women accessing treatment · by region

The access gap across Europe

Northern EU 72%
United Kingdom 61%
Western EU 58%
Southern EU 41%
Eastern EU 28%

Full country-by-country breakdown → research report · Source: ANBORELA analysis based on EUDA 2025

8 barriers · documented

Why women do not seek help

Social Double stigma: being a woman who consumes violates gender roles — intensified in pregnancy
Legal Fear of losing custody — most cited barrier in European literature
Economic 41% of women cannot afford unexpected health costs
Systemic Services designed around male schedules, culture and language
Trauma High prevalence of gender violence — consumption as coping mechanism
Logistic Incompatible schedules with caregiving responsibilities
Clinical Addiction undetected in primary care and mental health routes
Intersect. LGBTIQ+, migrants and ethnic minorities face compounded discrimination
~2,000 Overdose deaths among European women annually
17.9% EU adult women with heavy episodic drinking episodes
100K Women accessing specialised treatment each year in Europe

Full statistical analysis, sources and country-by-country data available in the research section.

Sources: EUDA 2025–2026 · WHO Europe 2024 · The Lancet 2024 · European Parliament 2025 · Pompidou Group

Research demo · Protocol preview

Interact with the conversational protocol

This demo illustrates the first-session flow of the ANBORELA system — designed for researchers, academic institutions and ethics committees. No personal data. No trace. Each session starts from zero.

Anonymous · no registration GDPR by design Static demo · no API
6-block first-session protocol — grounded in Prochaska stages of change and Miller & Rollnick motivational interviewing
Warm directive tone — designed for women in pre-contemplation, below the help-seeking threshold
Pending validation with principal investigator and ethics committee
A
ANBORELA Assistant Research prototype · Non-clinical support
DEMO
Write a message…
Researchers · Pre-deployment phase
You have completed the full first-session protocol. The live system is under ethical review. We invite academic institutions and public health bodies to co-design the validation study.
Request collaboration →
System architecture · Independence

Built outside Big Tech. By design.

ANBORELA is not hosted on Amazon Web Services, Microsoft Azure, or Google Cloud. It runs on independent European infrastructure — auditable, sovereign, and governed by EU law from its first line of code.

No Big Tech dependency

Not AWS, Azure or GCP. European infrastructure only — data stays within EU jurisdiction at all times.

Open to institutional audit

Academic and regulatory partners may request full architecture review and model behaviour audits.

Transparent AI architecture

Built on auditable AI models with full institutional transparency. Architecture and governance controlled by Anborela OÜ under EU law.

EU AI Act ready

Architecture designed in alignment with EU AI Act requirements for high-risk AI in health-adjacent domains.

Research roadmap

From pilot to European clinical validation

We are inviting institutions to co-design and validate each phase of the research programme.

Phase 01
Now Ethical review

Voluntary ethics submission

Voluntary submission to ethics committees before any real-world deployment. Seeking approval at national and university level across the EU.

Phase 02
Controlled pilot

University-supervised study

University-supervised study with consented participants in 2–3 countries. Ethics-first, GDPR-compliant, Big-Tech-independent.

Phase 03
Multi-country validation

EU-funded clinical study

EU-funded clinical-adjacent study with EUDA and Reitox network partners across multiple member states.

Phase 04
Horizon Europe

Full programme funding

Full programme funding application with academic co-applicants across Europe. Open to EU and UK partners.

The founder · Born from lived experience

The Founder

Person in long-term recovery  ·  Independent AI developer
"

I know from the inside what people in recovery need: continuous, non-judgmental support — available at any moment and adapted to each person's journey. Not a one-size-fits-all solution.

The founder of ANBORELA spent over three decades inside the cycle of addiction and recovery — through alcohol and cocaine — within Spain's public clinical system. That long and difficult road became the foundation of this project.

It brings what no research institution can offer alone: the authentic perspective of someone who has lived inside the system as a patient, a survivor, and now a builder committed to helping others find their way out.

For reasons of privacy and dignity, the founder's identity is kept anonymous. The lived experience — not the name — is what grounds this project's credibility for European ethics committees and funding bodies.

30+ Years of lived recovery experience
27 EU countries + UK targeted
100% Big-Tech independent
Ethics & safety · By design

Designed for oversight from day one

Every architectural decision in ANBORELA is built around ethical compliance, clinical safety boundaries, and institutional transparency.

🔒

GDPR by design

Anonymisation at point of collection. No real names, IDs or medical records stored. Encrypted European storage. Zero third-party data sales. Full data portability on request.

Non-clinical scope

The system does not diagnose, prescribe or replace professional care. Emergency referrals are hardcoded into the safety layer and always visible to the user at every stage.

Pre-deployment review

Submitted voluntarily to ethics review before any public access. Seeking national ministerial and university committee approval in multiple EU countries and the United Kingdom.

Is your institution ready to co-design the evidence?

We are inviting European universities, public health institutes and research bodies to join the scientific steering group.